Cite
Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.
MLA
Fahmy, Abdurrahman Muhammad, et al. “Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.” Journal of Pharmaceutical Sciences, vol. 110, no. 5, May 2021, pp. 2130–38. EBSCOhost, https://doi.org/10.1016/j.xphs.2020.12.013.
APA
Fahmy, A. M., Hassan, M., El-Setouhy, D. A., Tayel, S. A., & Al-mahallawi, A. M. (2021). Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation. Journal of Pharmaceutical Sciences, 110(5), 2130–2138. https://doi.org/10.1016/j.xphs.2020.12.013
Chicago
Fahmy, Abdurrahman Muhammad, Mariam Hassan, Doaa Ahmed El-Setouhy, Saadia Ahmed Tayel, and Abdulaziz Mohsen Al-mahallawi. 2021. “Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.” Journal of Pharmaceutical Sciences 110 (5): 2130–38. doi:10.1016/j.xphs.2020.12.013.